WeSay

Medical Cannabis Product Discovery and Review Platform

Business Software
Non Active, Mar 2021 ceased to operate

Company Overview

Snapshot

Founded in February 2019 by Yaron Burshtein and Ori Diamant, WeSay operates with 1–10 employees. The company announced a valuable product reviews resource for vendors and CBD users in September 2020.

Business overview

WeSay develops a B2B integrated solution designed to help individuals find suitable CBD/cannabis products through a matching algorithm. The platform enables brands to collect, manage, and respond to user-generated content. Operating within the Business Software sector, the company serves the medical cannabis and recreational cannabis markets, with a focus on e-Commerce Tools and Web platforms.

Strategic signal

In September 2020, WeSay announced a new product reviews resource for vendors and CBD users. This development signaled the company's focus on enhancing user engagement and providing valuable data to cannabis businesses, aiming to improve product discovery and consumer trust within the rapidly evolving cannabis market.

Company Intelligence Q&A

What is WeSay's primary business model?
WeSay operates with a B2B2C and B2B business model, providing solutions for both businesses and consumers in the cannabis product discovery space.
When was WeSay founded and by whom?
WeSay was founded in February 2019 by Yaron Burshtein and Ori Diamant.
What markets does WeSay target?
WeSay targets geomarkets including Western Europe and North America, focusing on the medical and recreational cannabis sectors.
What was a significant announcement from WeSay in 2020?
In September 2020, WeSay announced a valuable product reviews resource for vendors and CBD users, enhancing its platform's offerings.
What is the current operational status of WeSay?
WeSay is currently non-active, having ceased to operate in March 2021.